A real-world study gives the edge to Eli Lilly’s weight-loss drug, Amazon faces a potential antitrust hurdle in iRobot deal, and other news to start your day.
The Fed Won’t Talk About Rate Cuts. Why Traders Are Betting on Them.
2023-11-28 06:27
A real-world study gives the edge to Eli Lilly’s weight-loss drug, Amazon faces a potential antitrust hurdle in iRobot deal, and other news to start your day.

You Might Like...

Karpowership, Mulilo Have South African Grid-Access Rights Extended

SolarEdge Unveils Commercial Storage System at Intersolar 2023

Apple Photo Stream: iPhone users urged to check their library before photos are permanently deleted

Scientists discover reason why we experience deja vu

UK regulator issues notice to Snapchat over privacy risks posed by AI chatbot

Google Cloud to open office in El Salvador in seven-year partnership

Scientists make 'shocking' discovery that life could be hiding on Saturn's moon

Stocks Poised for Muted Open